Gastrointestinal perforation associated with novel antineoplastic agents: A real-world study based on the FDA Adverse Event Reporting System

Purpose: Gastrointestinal perforation (GIP) is a fatal adverse event (AE). The AE of GIP induced by novel antineoplastic agents has attracted attention recently. We aimed to explore the AE signals of GIP related to novel antineoplastic agents comprehensively based on the FDA Adverse Event Reporting...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, Zicheng, Zhu, Haibin, Chen, Hongjun, Zhu, Lifei, Liao, Xiaolan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Science archive
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9990630/
https://www.ncbi.nlm.nih.gov/pubmed/36942297
http://dx.doi.org/10.3389/jpps.2023.11235

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9990630/
https://www.ncbi.nlm.nih.gov/pubmed/36942297
http://dx.doi.org/10.3389/jpps.2023.11235

Ejemplares similares